Jump to content

NIH Begins Trial of Hydroxychloroquine and Azithromycin for Coronavirus


perugu_vada

Recommended Posts

https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19
 

The National Institutes of Health (NIH) has begun a clinical trial testing the effectiveness of combining antimalarial drug hydroxychloroquine with antibiotic azithromycin as a treatment for COVID-19.

The controlled trial is the latest of several attempts to test the safety and efficacy of the drugs. The trial began Thursday and will involve 2,000 U.S. adults who are infected with the coronavirus and have symptoms like shortness of breath, cough and fever.

Most of the participants are expected to be people over the age of 60 with conditions that put them at a higher risk for COVID-19 complications, such as diabetes or high blood pressure.

 

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...